1. Ito, S., Koshino, A., Komura, M., Kato, S., Otani, T., Wang, C., Ueki, A., Takahashi, H., Ebi, M., Ogasawara, N., Tsuzuki, T., Kasai, K., Kasugai, K., Takiguchi, S., Takahashi, S., Inaguma, S.: Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers. Pathol Int, 74:13-25, 2024.
2. Denda, Y., Matsuo, Y., Nonoyama, K., Murase, H., Kato, T., Hayashi, Y., Imafuji, H., Saito, K., Morimoto, M., Kato, H., Yoshida, M., Naitoh, I., Hayashi, K., Ogawa, R., Takahashi, H., Takiguchi, S.: Simultaneous presentation and resection of esophageal cancer and metastasis to the pancreas: A case report and literature review. Mol Clin Oncol, 20:2, 2024.
3. Komura, M., Wang, C., Ito, S., Kato, S., Ueki, A., Ebi, M., Ogasawara, N., Tsuzuki, T., Kasai, K., Kasugai, K., Takiguchi, S., Takahashi, S., Inaguma, S.: Simultaneous expression of CD70 and POSTN in cancer-associated fibroblasts, predicts worse survival of colorectal cancer patients. Int J Mol Sci, 25:2537, 2024.
4. Morikawa, T., Iwatsuki, S., Naiki-Ito, A., Gonda, M., Taguchi, K., Naiki, T., Hamamoto, S., Okada, A., Yasui, T.: Urothelial carcinoma occurring in a defunctionalized bladder after urinary diversion due to the bladder exstrophy-epispadias complex. IJU Case Rep, 7:101-104, 2024.
5. Aoki, M., Naiki, T., Naiki-Ito, A., Morikawa, T., Matsuyama, N., Torii, K., Kato, T., Maruyama, T., Inaguma, S., Yasui, T.: Successful treatment with enfortumab-vedotin of metastatic signet ring cell cancer expressing nectin-4 and originating from the bladder. IJU Case Rep, 7:110-114, 2024.
6. Morikawa, T., Naiki, T., Sugiyama, Y., Naiki-Ito, A., Nagai, T., Etani, T., Iida, K., Isobe, T., Noda, Y., Shimizu, N., Aoki, M., Gonda, M., Banno, R., Kubota, H., Ando, R., Umemoto, Y., Kawai, N., Yasui, T.: C-reactive protein is a potential prognostic marker in patient with advanced or metastatic urothelial carcinoma treated with enfortumab vedotin: A multi-center retrospective study. Cancers, 16:1725, 2024.
7. Uno, K., Shimura, R., Inaguma, S., Kuroyanagi, K., Nishigaki, R., Kannno, T., Sasaki, M., Fukusada, S., Sugimura, N., Mizuno, Y., Nukui, T., Kojima, Y., Tanaka, M., Ozeki, K., Kubota, E., Takahashi, S., Kataoka, H.: Clinical impact of proton pump inhibitor and potassium-competitive acid blocker for predicting the curability of endoscopic resection in ulcerative early gastric cancer. Digestion, 105:192-200, 2024.
8. Hori, Y., Naitoh, I., Naiki-Ito, A., Kawai, T., Yoshida, M., Kato, A., Kachi, K., Sahashi, H., Adachi, A., Toyohara, T., Kito, Y., Yamamoto, T., Takahashi, S., Kataoka, H.: Incidence of pancreatic injury and pancreatitis in patients treated with immune checkpoint inhibitors. Clin Transl Gastroenterol, 15:e00667, 2024.
9. Ito, S., Koshino, A., Komura, M., Otani, T., Wang, C., Ueki, A., Kato, S., Takahashi, H., Ebi, M., Ogasawara, N., Tsuzuki, T., Kasai, K., Kasugai, K., Takiguchi, S., Takahashi, S., Inaguma, S.: Characterization of colorectal cancer by hierarchical clustering analyses for five stroma-related markers. J Pathol Clin Res, 10:e12386, 2024.
10. Hori, Y., Kawai, T., Naiki-Ito, A., Naitoh, I., Kato, A., Kataoka, H.: Asymptomatic pancreatic enlargement without pancreatic enzyme elevation: a rare case of immune checkpoint inhibitor-associated pancreatitis. Gastroenterol Rep, 2024：12, goae064, 2024.
11. Inaguma, S., Wang, C., Ito, S., Ueki, A., Lasota, J., Czapiewski, P., Renata Langfort, R., Rys, J., Szpor, J., Waloszczyk, P., Okoń, K., Biernat, W., Takiguchi, S., Schrump, D.S., Miettinen, M., Takahashi, S.: Characterization of pleural mesothelioma by hierarchical clustering analyses using immune cells within tumor microenvironment. Pathobiology, in press.
12. Kato, S., Koshino, A., Lasota, J., Komura, M., Wang, C., Ebi, M., Ogasawara, N., Kojima, K., Tsuzuki, T., Kasai, K., Takahashi, S., Miettinen, M., Kasugai, K., Inaguma, S.: Use of SATB2 and CDX2 immunohistochemistry to characterize and diagnose colorectal cancer. Appl Immunohistochem Mol Morphol, in press.
13. Naiki-Ito, A., Yeewa, R., Xiaochen, K., Taychaworaditsakul, W., Naiki, T., Kato, H., Nagayasu, Y., Chewonarin, T., Takahashi, S.: Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis via inhibition of NF-κB and JNK signaling, Food Funct, in press.
14. 貫井嵩之、箕輪彬久、水島隆史、浦壁憲司、岡山幸平、鈴木健人、鈴木雄太、羽根田賢一、高橋智、奥村文浩、まれな内視鏡像を呈し鑑別に苦慮した乳癌胃転移の1例. 日本消化器病学会雑誌、121:117-126, 2024.